Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Gene Therapy Market Expected to Grow Between 2025 And 2029?

The market size for gene therapy has experienced significant expansion in the recent past. The magnitude is projected to escalate from a whopping $12.52 billion in 2024, reaching up to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. Factors contributing to growth during the historic period include an increase in pharmaceutical research and development spending, surge in collaborations between the private sector and government, state-level investments, and an upsurge in instances of spinal muscular atrophy.

The gene therapy market is projected to experience significant expansion in the coming years, anticipated to reach $31.48 billion by 2029 with a remarkable compound annual growth rate (CAGR) of 17.8%. The expansion anticipated in the projection period finds its roots in the escalation of cancer incidences, the expanding elderly demographic, heightened pharmaceutical sector investment in R&D, and an amplified emphasis on gene therapy. Upcoming market trends in the projection time frame encompass improving business functions via regulatory approvals, augmenting commercial activities via strategic alliances and associations, stretching business scope with strategic investments, and fortifying operational capacities via business enlargement.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gene Therapy Market?

The significant increase in occurrences of cancer and other targeted diseases necessitates effective treatments, thus fueling the expansion of the gene therapy market. The escalating cancer instances worldwide are predicted to further the growth of the gene therapy market in the upcoming period. For example, the American Cancer Society reported in January 2022 that there are likely to be approximately 1.9 million fresh cancer cases and about 609,360 cancer-associated fatalities in the US alone, averaging about 1,670 deaths per day. The top four prevalent types of cancer globally; lung, prostate, bowel, and female breast cancer, make up 43 percent of all new cancer diagnoses. Therefore, the global surge in cancer occurrence rate is predicted to propel the demand for the gene therapy market in the ensuing years. Gene therapy serves as one of the most potent treatments in oncology, where new genes are infused into a cancerous cell or its accompanying tissue to either induce cell death or inhibit cancer proliferation.

Which Key Market Segments Comprise the Gene Therapy Market and Drive Its Revenue Growth?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Areas Are Leading Regions in the Gene Therapy Market Expansion Across the Globe?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theGene Therapy Market Over the Coming Years?

The adoption of machine learning and artificial intelligence within the gene therapy market is slowly but steadily increasing. Artificial Intelligence (AI) is essentially the replication of human cognition by machines, while machine learning operates as a subset of AI. Applications of machine learning and AI within gene therapy help companies perform in-depth data analyses, generate insights into tumor-immune cell interactions, and yield more precise evaluations of tissue specimens, an aspect often subject to differing interpretations. Case in point, Form Bio, a life-science software firm based in the US, unveiled FORMsightAI in May 2023. This novel AI solution predicts and optimizes the production outputs of both cell and gene therapy constructs. The FORMsightAI package merges innovative, flexible AI models with Form Bio’s foundational platform and a team of accomplished experts in computational life sciences with a depth of knowledge in biology, bioinformatics, and data science. FORMsightAI tackles frequent challenges such as construct truncations and manufacturing contaminations often experienced by cell and gene therapy developers. These issues majorly contribute to low production yields, delayed market entry, and therapeutic safety concerns.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Is the Gene Therapy Market Conceptually Defined?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model